Identification of microRNAs involved in Alzheimer’s progression using a rabbit model of the disease

Qing Yan Liu, Marilyn N.Vera Chang, Joy X. Lei, Roger Koukiekolo, Brandon Smith, Dongling Zhang, Ghribi Othman

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Alzheimer’s disease (AD) is the most common neurodegenerative disorder characterized by the presence of extracellular plaques of β-amyloid peptides and intracellular tangles of hyperphosphorylated tau proteins in the brain. The vast majority of cases are late onset AD (LOAD), which are genetically heterogeneous and occur sporadically. High blood cholesterol is suggested to be a risk factor for this disease. Several neuropathological changes of LOAD can be reproduced by supplementing a rabbit’s diet with 2% cholesterol for 12 weeks. Accumulating data in the literature suggest that microRNAs (miRNA) participate in the development of AD pathology. The present study focuses on the survey of changes of miRNA expression in rabbit brains during the progression of AD-like pathology using microarray followed by Taq-Man qRT-PCR analyses. Out of 1769 miRNA probes used in the experiments, 99 miRNAs were found to be present in rabbit brain, 57 were newly identified as miRNAs from rabbit brain. Eleven miRNAs showed significant changes over AD-like pathology progression. Among them, the changes of miR-125b, miR-98, miR-107, miR-30, along with 3 members of the let-7 family were similar to those observed in human AD samples, whereas the expression patterns of miR-15a, miR-26b, miR-9 and miR-576-3p were unique to this rabbit LOAD model. The significant up regulation of miR-26b is consistent with the decrease of leptin levels in the brains of cholesterol fed rabbit model for AD, confirming that miR-26b is indeed regulated by leptin and that both leptin and miR-26b may be involved in cholesterol induced AD-like pathology.

Original languageEnglish (US)
Pages (from-to)33-44
Number of pages12
JournalAmerican Journal of Neurodegenerative Diseases
Volume3
Issue number1
StatePublished - 2014
Externally publishedYes

Fingerprint

MicroRNAs
Alzheimer Disease
Rabbits
Leptin
Cholesterol
Pathology
Brain
tau Proteins
Amyloid Plaques
Neurodegenerative Diseases
Up-Regulation
Diet
Polymerase Chain Reaction
Peptides

Keywords

  • Alzheimer’s disease
  • Leptin
  • Let-7
  • MicroRNA
  • MiR-26b
  • Rabbit AD model

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

Identification of microRNAs involved in Alzheimer’s progression using a rabbit model of the disease. / Liu, Qing Yan; Chang, Marilyn N.Vera; Lei, Joy X.; Koukiekolo, Roger; Smith, Brandon; Zhang, Dongling; Othman, Ghribi.

In: American Journal of Neurodegenerative Diseases, Vol. 3, No. 1, 2014, p. 33-44.

Research output: Contribution to journalArticle

Liu, Qing Yan ; Chang, Marilyn N.Vera ; Lei, Joy X. ; Koukiekolo, Roger ; Smith, Brandon ; Zhang, Dongling ; Othman, Ghribi. / Identification of microRNAs involved in Alzheimer’s progression using a rabbit model of the disease. In: American Journal of Neurodegenerative Diseases. 2014 ; Vol. 3, No. 1. pp. 33-44.
@article{b61250ddda5f4407b78414c3af270b5d,
title = "Identification of microRNAs involved in Alzheimer’s progression using a rabbit model of the disease",
abstract = "Alzheimer’s disease (AD) is the most common neurodegenerative disorder characterized by the presence of extracellular plaques of β-amyloid peptides and intracellular tangles of hyperphosphorylated tau proteins in the brain. The vast majority of cases are late onset AD (LOAD), which are genetically heterogeneous and occur sporadically. High blood cholesterol is suggested to be a risk factor for this disease. Several neuropathological changes of LOAD can be reproduced by supplementing a rabbit’s diet with 2{\%} cholesterol for 12 weeks. Accumulating data in the literature suggest that microRNAs (miRNA) participate in the development of AD pathology. The present study focuses on the survey of changes of miRNA expression in rabbit brains during the progression of AD-like pathology using microarray followed by Taq-Man qRT-PCR analyses. Out of 1769 miRNA probes used in the experiments, 99 miRNAs were found to be present in rabbit brain, 57 were newly identified as miRNAs from rabbit brain. Eleven miRNAs showed significant changes over AD-like pathology progression. Among them, the changes of miR-125b, miR-98, miR-107, miR-30, along with 3 members of the let-7 family were similar to those observed in human AD samples, whereas the expression patterns of miR-15a, miR-26b, miR-9 and miR-576-3p were unique to this rabbit LOAD model. The significant up regulation of miR-26b is consistent with the decrease of leptin levels in the brains of cholesterol fed rabbit model for AD, confirming that miR-26b is indeed regulated by leptin and that both leptin and miR-26b may be involved in cholesterol induced AD-like pathology.",
keywords = "Alzheimer’s disease, Leptin, Let-7, MicroRNA, MiR-26b, Rabbit AD model",
author = "Liu, {Qing Yan} and Chang, {Marilyn N.Vera} and Lei, {Joy X.} and Roger Koukiekolo and Brandon Smith and Dongling Zhang and Ghribi Othman",
year = "2014",
language = "English (US)",
volume = "3",
pages = "33--44",
journal = "American Journal of Neurodegenerative Diseases",
issn = "2165-591X",
publisher = "e-Century Publishing Corporation",
number = "1",

}

TY - JOUR

T1 - Identification of microRNAs involved in Alzheimer’s progression using a rabbit model of the disease

AU - Liu, Qing Yan

AU - Chang, Marilyn N.Vera

AU - Lei, Joy X.

AU - Koukiekolo, Roger

AU - Smith, Brandon

AU - Zhang, Dongling

AU - Othman, Ghribi

PY - 2014

Y1 - 2014

N2 - Alzheimer’s disease (AD) is the most common neurodegenerative disorder characterized by the presence of extracellular plaques of β-amyloid peptides and intracellular tangles of hyperphosphorylated tau proteins in the brain. The vast majority of cases are late onset AD (LOAD), which are genetically heterogeneous and occur sporadically. High blood cholesterol is suggested to be a risk factor for this disease. Several neuropathological changes of LOAD can be reproduced by supplementing a rabbit’s diet with 2% cholesterol for 12 weeks. Accumulating data in the literature suggest that microRNAs (miRNA) participate in the development of AD pathology. The present study focuses on the survey of changes of miRNA expression in rabbit brains during the progression of AD-like pathology using microarray followed by Taq-Man qRT-PCR analyses. Out of 1769 miRNA probes used in the experiments, 99 miRNAs were found to be present in rabbit brain, 57 were newly identified as miRNAs from rabbit brain. Eleven miRNAs showed significant changes over AD-like pathology progression. Among them, the changes of miR-125b, miR-98, miR-107, miR-30, along with 3 members of the let-7 family were similar to those observed in human AD samples, whereas the expression patterns of miR-15a, miR-26b, miR-9 and miR-576-3p were unique to this rabbit LOAD model. The significant up regulation of miR-26b is consistent with the decrease of leptin levels in the brains of cholesterol fed rabbit model for AD, confirming that miR-26b is indeed regulated by leptin and that both leptin and miR-26b may be involved in cholesterol induced AD-like pathology.

AB - Alzheimer’s disease (AD) is the most common neurodegenerative disorder characterized by the presence of extracellular plaques of β-amyloid peptides and intracellular tangles of hyperphosphorylated tau proteins in the brain. The vast majority of cases are late onset AD (LOAD), which are genetically heterogeneous and occur sporadically. High blood cholesterol is suggested to be a risk factor for this disease. Several neuropathological changes of LOAD can be reproduced by supplementing a rabbit’s diet with 2% cholesterol for 12 weeks. Accumulating data in the literature suggest that microRNAs (miRNA) participate in the development of AD pathology. The present study focuses on the survey of changes of miRNA expression in rabbit brains during the progression of AD-like pathology using microarray followed by Taq-Man qRT-PCR analyses. Out of 1769 miRNA probes used in the experiments, 99 miRNAs were found to be present in rabbit brain, 57 were newly identified as miRNAs from rabbit brain. Eleven miRNAs showed significant changes over AD-like pathology progression. Among them, the changes of miR-125b, miR-98, miR-107, miR-30, along with 3 members of the let-7 family were similar to those observed in human AD samples, whereas the expression patterns of miR-15a, miR-26b, miR-9 and miR-576-3p were unique to this rabbit LOAD model. The significant up regulation of miR-26b is consistent with the decrease of leptin levels in the brains of cholesterol fed rabbit model for AD, confirming that miR-26b is indeed regulated by leptin and that both leptin and miR-26b may be involved in cholesterol induced AD-like pathology.

KW - Alzheimer’s disease

KW - Leptin

KW - Let-7

KW - MicroRNA

KW - MiR-26b

KW - Rabbit AD model

UR - http://www.scopus.com/inward/record.url?scp=84980052130&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84980052130&partnerID=8YFLogxK

M3 - Article

VL - 3

SP - 33

EP - 44

JO - American Journal of Neurodegenerative Diseases

JF - American Journal of Neurodegenerative Diseases

SN - 2165-591X

IS - 1

ER -